S&P 500   3,373.23 (-0.38%)
DOW   29,219.98 (-0.44%)
QQQ   234.78 (-0.93%)
AAPL   320.30 (-1.03%)
FB   214.58 (-1.34%)
MSFT   184.42 (-1.53%)
GOOGL   1,516.99 (-0.52%)
AMZN   2,153.13 (-0.79%)
CGC   22.31 (+2.48%)
NVDA   308.70 (-1.91%)
BABA   218.04 (-1.85%)
MU   59.00 (-1.65%)
GE   12.53 (-0.63%)
TSLA   899.41 (-1.96%)
AMD   57.27 (-2.77%)
T   38.61 (+0.44%)
ACB   1.68 (-1.75%)
F   8.03 (+0.38%)
NFLX   386.00 (-0.05%)
PRI   136.40 (+0.52%)
BAC   34.85 (+0.37%)
DIS   140.37 (-0.66%)
GILD   67.00 (-0.52%)
S&P 500   3,373.23 (-0.38%)
DOW   29,219.98 (-0.44%)
QQQ   234.78 (-0.93%)
AAPL   320.30 (-1.03%)
FB   214.58 (-1.34%)
MSFT   184.42 (-1.53%)
GOOGL   1,516.99 (-0.52%)
AMZN   2,153.13 (-0.79%)
CGC   22.31 (+2.48%)
NVDA   308.70 (-1.91%)
BABA   218.04 (-1.85%)
MU   59.00 (-1.65%)
GE   12.53 (-0.63%)
TSLA   899.41 (-1.96%)
AMD   57.27 (-2.77%)
T   38.61 (+0.44%)
ACB   1.68 (-1.75%)
F   8.03 (+0.38%)
NFLX   386.00 (-0.05%)
PRI   136.40 (+0.52%)
BAC   34.85 (+0.37%)
DIS   140.37 (-0.66%)
GILD   67.00 (-0.52%)
S&P 500   3,373.23 (-0.38%)
DOW   29,219.98 (-0.44%)
QQQ   234.78 (-0.93%)
AAPL   320.30 (-1.03%)
FB   214.58 (-1.34%)
MSFT   184.42 (-1.53%)
GOOGL   1,516.99 (-0.52%)
AMZN   2,153.13 (-0.79%)
CGC   22.31 (+2.48%)
NVDA   308.70 (-1.91%)
BABA   218.04 (-1.85%)
MU   59.00 (-1.65%)
GE   12.53 (-0.63%)
TSLA   899.41 (-1.96%)
AMD   57.27 (-2.77%)
T   38.61 (+0.44%)
ACB   1.68 (-1.75%)
F   8.03 (+0.38%)
NFLX   386.00 (-0.05%)
PRI   136.40 (+0.52%)
BAC   34.85 (+0.37%)
DIS   140.37 (-0.66%)
GILD   67.00 (-0.52%)
S&P 500   3,373.23 (-0.38%)
DOW   29,219.98 (-0.44%)
QQQ   234.78 (-0.93%)
AAPL   320.30 (-1.03%)
FB   214.58 (-1.34%)
MSFT   184.42 (-1.53%)
GOOGL   1,516.99 (-0.52%)
AMZN   2,153.13 (-0.79%)
CGC   22.31 (+2.48%)
NVDA   308.70 (-1.91%)
BABA   218.04 (-1.85%)
MU   59.00 (-1.65%)
GE   12.53 (-0.63%)
TSLA   899.41 (-1.96%)
AMD   57.27 (-2.77%)
T   38.61 (+0.44%)
ACB   1.68 (-1.75%)
F   8.03 (+0.38%)
NFLX   386.00 (-0.05%)
PRI   136.40 (+0.52%)
BAC   34.85 (+0.37%)
DIS   140.37 (-0.66%)
GILD   67.00 (-0.52%)
Log in

CVE:TLT - Theralase Technologies Stock Price, Forecast & News

C$0.26
-0.01 (-3.64 %)
(As of 02/20/2020 04:00 PM ET)
Today's Range
C$0.26
Now: C$0.27
C$0.27
50-Day Range
C$0.26
MA: C$0.30
C$0.38
52-Week Range
C$0.20
Now: C$0.27
C$0.60
Volume429,362 shs
Average Volume323,232 shs
Market CapitalizationC$54.13 million
P/E RatioN/A
Dividend Yield2.03%
BetaN/A
Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds (PDCs) and their associated drug formulations to destroy various cancers in Canada, the United States, and internationally. It operates in two divisions, Anti-Cancer Therapy and Medical Laser Technology. The company also designs, develops, manufactures, and commercializes medical laser systems and other technologies for the activation of PDCs; designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions. Its products include TLC-1000, TLC-2000, and controllerless series laser technology products for the elimination of pain, reduction of inflammation, and acceleration of healing, as well as TLC-1000 and TLC-2000 accessories; and Theralase therapeutic laser treatments for patients, including pain management, arthritis, wound healing, addiction rehabilitation and weight loss, and anti-aging, as well as companion animals and equine. The company sells its products to healthcare practitioners. Theralase Technologies Inc. was founded in 1995 and is headquartered in Toronto, Canada.

Industry, Sector and Symbol

Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-416-6995273

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$972,333.00
Cash FlowC$0.07 per share
Book ValueC$0.08 per share

Profitability

Miscellaneous

Employees20
Market CapC$54.13 million
Next Earnings Date3/6/2020 (Estimated)
OptionableOptionable

Receive TLT News and Ratings via Email

Sign-up to receive the latest news and ratings for TLT and its competitors with MarketBeat's FREE daily newsletter.


Theralase Technologies (CVE:TLT) Frequently Asked Questions

What is Theralase Technologies' stock symbol?

Theralase Technologies trades on the Canadian Venture Exchange (CVE) under the ticker symbol "TLT."

How were Theralase Technologies' earnings last quarter?

Theralase Technologies Inc. (CVE:TLT) posted its quarterly earnings data on Friday, November, 29th. The company reported ($0.01) EPS for the quarter, meeting the Zacks' consensus estimate of ($0.01). The business earned $0.14 million during the quarter, compared to analysts' expectations of $0.30 million. View Theralase Technologies' Earnings History.

When is Theralase Technologies' next earnings date?

Theralase Technologies is scheduled to release their next quarterly earnings announcement on Friday, March 6th 2020. View Earnings Estimates for Theralase Technologies.

Has Theralase Technologies been receiving favorable news coverage?

News articles about TLT stock have been trending somewhat negative on Thursday, InfoTrie Sentiment reports. The research firm scores the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Theralase Technologies earned a coverage optimism score of -1.4 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Theralase Technologies.

Who are some of Theralase Technologies' key competitors?

What other stocks do shareholders of Theralase Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Theralase Technologies investors own include IMRIS (IMRSQ), Cross Timbers Royalty Trust (CRT), AGNC Investment (AGNC), Gladstone Investment (GAIN), Prospect Capital (PSEC), Sesen Bio (SESN), Ford Motor (F), Prologis (PLD), InfraCap MLP ETF (AMZA) and Aurora Cannabis (ACB).

Who are Theralase Technologies' key executives?

Theralase Technologies' management team includes the folowing people:
  • Ms. Kristina Hachey, CFO & Director
  • Dr. Arkady Mandel, Chief Scientific Officer & Director
  • Mr. Roger John Dumoulin-White, Director of Bus. Devel.
  • Dr. Shawn Shirazi Ph.D., Chief Exec. Officer
  • Mr. David M. Groves B.A, Pres of World Trade Division

How do I buy shares of Theralase Technologies?

Shares of TLT and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Theralase Technologies' stock price today?

One share of TLT stock can currently be purchased for approximately C$0.27.

How big of a company is Theralase Technologies?

Theralase Technologies has a market capitalization of C$54.13 million and generates C$972,333.00 in revenue each year. Theralase Technologies employs 20 workers across the globe.View Additional Information About Theralase Technologies.

What is Theralase Technologies' official website?

The official website for Theralase Technologies is http://theralase.com/.

How can I contact Theralase Technologies?

Theralase Technologies' mailing address is 1945 Queen St E, TORONTO, ON M4L 1H7, Canada. The company can be reached via phone at +1-416-6995273.


MarketBeat Community Rating for Theralase Technologies (CVE TLT)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  61 (Vote Outperform)
Underperform Votes:  52 (Vote Underperform)
Total Votes:  113
MarketBeat's community ratings are surveys of what our community members think about Theralase Technologies and other stocks. Vote "Outperform" if you believe TLT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TLT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel